Cyberonics names new vice president of R&D

Dr Morris joins Cyberonics from InnerPulse, a privately held cardiology-focused medical technology company in North Carolina, where he has served as director of program management and operations since November 2007.

Prior to InnerPulse, Dr Morris was employed in several different positions with Guidant and its successor, Boston Scientific, over a period of 11 years, including senior research engineer; manager of R&D; director of R&D; field clinical representative; and director of marketing.

Dan Moore, Cyberonics’s president and CEO, said: “Milton brings substantial expertise in algorithm development that will be helpful in our seizure detection and prediction programs.

“He has extensive experience in designing, running clinical trials for and launching active implantable devices and is the ideal person to lead our R&D efforts as we focus on a number of key long-term growth drivers, including stimulation parameters and telemedicine. We are pleased to have Milton joining our team.”